|
1
|
Mohammad IS, He W and Yin L: Understanding
of human ATP binding cassette superfamily and novel multidrug
resistance modulators to overcome MDR. Biomed Pharmacother.
100:335–348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang L, Tan RZ, Zhang ZX, Yin R, Zhang YL,
Cui WJ and He T: Association between Twist and multidrug resistance
gene-associated proteins in Taxol®-resistant MCF-7 cells
and a 293 cell model of Twist overexpression. Oncol Lett.
15:1058–1066. 2018.PubMed/NCBI
|
|
3
|
Fukuda Y and Schuetz JD: ABC transporters
and their role in nucleoside and nucleotide drug resistance.
Biochem Pharmacol. 83:1073–1083. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen ZS and Tiwari AK: Multidrug
resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic
diseases. FEBS J. 278:3226–3245. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu YR, Liang L, Zhao JM, Zhang Y, Zhang
M, Zhong WL, Zhang Q, Wei JJ, Li M, Yuan J, et al: Twist1 confers
multidrug resistance in colon cancer through upregulation of
ATP-binding cassette transporters. Oncotarget. 8:52901–52912.
2017.PubMed/NCBI
|
|
6
|
Norouzi-Barough L, Sarookhani M, Salehi R,
Sharifi M and Moghbelinejad S: CRISPR/Cas9, a new approach to
successful knockdown of ABCB1/P-glycoprotein and reversal of
chemosensitivity in human epithelial ovarian cancer cell line. Iran
J Basic Med Sci. 21:181–187. 2018.PubMed/NCBI
|
|
7
|
Ceballos MP, Rigalli JP, Cere LI, Semeniuk
M, Catania VA and Ruiz ML: ABC transporters: Regulation and
association with multidrug resistance in hepatocellular carcinoma
and colorectal carcinoma. Curr Med Chem. 2018.
|
|
8
|
Maia RC, Vasconcelos FC, Souza PS and
Rumjanek VM: Towards comprehension of the ABCB1/P-glycoprotein role
in chronic myeloid leukemia. Molecules. 23:2018. View Article : Google Scholar
|
|
9
|
Assaraf YG: Molecular basis of antifolate
resistance. Cancer Metastasis Rev. 26:153–181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Borst P, Evers R, Kool M and Wijnholds J:
A family of drug transporters: The multidrug resistance-associated
proteins. J Natl Cancer Inst. 92:1295–1302. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dean M, Hamon Y and Chimini G: The human
ATP-binding cassette (ABC) transporter superfamily. J Lipid Res.
42:1007–1017. 2001.PubMed/NCBI
|
|
12
|
Wang J, Yunyun Z, Wang L, Chen X and Zhu
Z: ABCG2 confers promotion in gastric cancer through modulating
downstream CRKL in vitro combining with biostatistics mining.
Oncotarget. 8:5256–5267. 2017.PubMed/NCBI
|
|
13
|
Kaehler M, Ruemenapp J, Gonnermann D,
Nagel I, Bruhn O, Haenisch S, Ammerpohl O, Wesch D, Cascorbi I and
Bruckmueller H: MicroRNA-212/ABCG2-axis contributes to development
of imatinib-resistance in leukemic cells. Oncotarget.
8:92018–92031. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ling V: Multidrug resistance: Molecular
mechanisms and clinical relevance. Cancer Chemother Pharmacol (40
Suppl). S3–S8. 1997. View Article : Google Scholar
|
|
16
|
Xu W, Liu H, Liu ZG, Wang HS, Zhang F,
Wang H, Zhang J, Chen JJ, Huang HJ, Tan Y, et al: Histone
deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation
and stabilization of Snail to promote metastasis of hepatoma cells.
Cancer Lett. 420:1–13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang GM, Wang HS, Zhang F, Zhang KS, Liu
ZC, Fang R, Wang H, Cai SH and Du J: Histone deacetylase inhibitor
induction of epithelial-mesenchymal transitions via up-regulation
of Snail facilitates cancer progression. Biochim Biophys Acta.
1833:663–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Botrugno OA, Santoro F and Minucci S:
Histone deacetylase inhibitors as a new weapon in the arsenal of
differentiation therapies of cancer. Cancer Lett. 280:134–144.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ni X, Li L and Pan G: HDAC
inhibitor-induced drug resistance involving ATP-binding cassette
transporters (Review). Oncol Lett. 9:515–521. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Di Costanzo A, Del Gaudio N, Conte L,
Dell'Aversana C, Vermeulen M, de Thé H, Migliaccio A, Nebbioso A
and Altucci L: The HDAC inhibitor SAHA regulates CBX2 stability via
a SUMO-triggered ubiquitin-mediated pathway in leukemia. Oncogene.
37:2559–2572. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stimson L and La Thangue NB: Biomarkers
for predicting clinical responses to HDAC inhibitors. Cancer Lett.
280:177–183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H, Huang C, Zhao L, Zhang H, Yang JM,
Luo P, Zhan BX, Pan Q, Li J and Wang BL: Histone deacetylase
inhibitors regulate P-gp expression in colorectal cancer via
transcriptional activation and mRNA stabilization. Oncotarget.
7:49848–49858. 2016.PubMed/NCBI
|
|
23
|
Zhao L, Bin S, He HL, Yang JM, Pu YC, Gao
CH, Wang H and Wang BL: Sodium butyrate increases P-gp expression
in lung cancer by upregulation of STAT3 and mRNA stabilization of
ABCB1. Anticancer Drugs. 29:227–233. 2018.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sharom FJ: The P-glycoprotein multidrug
transporter. Essays Biochem. 50:161–178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han Z and Shi L: Long non-coding RNA
LUCAT1 modulates methotrexate resistance in osteosarcoma via
miR-200c/ABCB1 axis. Biochem Biophys Res Commun. 495:947–953. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Robey RW, Zhan Z, Piekarz RL, Kayastha GL,
Fojo T and Bates SE: Increased MDR1 expression in normal and
malignant peripheral blood mononuclear cells obtained from patients
receiving depsipeptide (FR901228, FK228, NSC630176). Clin Cancer
Res. 12:1547–1555. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tabe Y, Konopleva M, Contractor R, Munsell
M, Schober WD, Jin L, Tsutsumi-Ishii Y, Nagaoka I, Igari J and
Andreeff M: Up-regulation of MDR1 and induction of doxorubicin
resistance by histone deacetylase inhibitor depsipeptide (FK228)
and ATRA in acute promyelocytic leukemia cells. Blood.
107:1546–1554. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hauswald S, Duque-Afonso J, Wagner MM,
Schertl FM, Lübbert M, Peschel C, Keller U and Licht T: Histone
deacetylase inhibitors induce a very broad, pleiotropic anticancer
drug resistance phenotype in acute myeloid leukemia cells by
modulation of multiple ABC transporter genes. Clin Cancer Res.
15:3705–3715. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
To KK, Polgar O, Huff LM, Morisaki K and
Bates SE: Histone modifications at the ABCG2 promoter following
treatment with histone deacetylase inhibitor mirror those in
multidrug-resistant cells. Mol Cancer Res. 6:151–164. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Valdez BC, Li Y, Murray D, Brammer JE, Liu
Y, Hosing C, Nieto Y, Champlin RE and Andersson BS: Differential
effects of histone deacetylase inhibitors on cellular drug
transporters and their implications for using epigenetic modifiers
in combination chemotherapy. Oncotarget. 7:63829–63838. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ménez C, Mselli-Lakhal L, Foucaud-Vignault
M, Balaguer P, Alvinerie M and Lespine A: Ivermectin induces
P-glycoprotein expression and function through mRNA stabilization
in murine hepatocyte cell line. Biochem Pharmacol. 83:269–278.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim SH, Kang HJ, Na H and Lee MO:
Trichostatin A enhances acetylation as well as protein stability of
ERalpha through induction of p300 protein. Breast Cancer Res.
12:R222010. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Barski A, Cuddapah S, Cui K, Roh TY,
Schones DE, Wang Z, Wei G, Chepelev I and Zhao K: High-resolution
profiling of histone methylations in the human genome. Cell.
129:823–837. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koch CM, Andrews RM, Flicek P, Dillon SC,
Karaöz U, Clelland GK, Wilcox S, Beare DM, Fowler JC, Couttet P, et
al: The landscape of histone modifications across 1% of the human
genome in five human cell lines. Genome Res. 17:691–707. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rosenfeld JA, Wang Z, Schones DE, Zhao K,
DeSalle R and Zhang MQ: Determination of enriched histone
modifications in non-genic portions of the human genome. BMC
Genomics. 10:1432009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Witt O, Deubzer HE, Milde T and Oehme I:
HDAC family: What are the cancer relevant targets? Cancer Lett.
277:8–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lee HA, Song MJ, Seok YM, Kang SH, Kim SY
and Kim I: Histone deacetylase 3 and 4 complex stimulates the
transcriptional activity of the mineralocorticoid receptor. PLoS
One. 10:e01368012015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vaute O, Nicolas E, Vandel L and Trouche
D: Functional and physical interaction between the histone methyl
transferase Suv39H1 and histone deacetylases. Nucleic Acids Res.
30:475–481. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Johnson ZL and Chen J: ATP binding enables
substrate release from multidrug resistance protein 1. Cell.
172:81–89.e10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Valdez BC, Nieto Y, Murray D, Li Y, Wang
G, Champlin RE and Andersson BS: Epigenetic modifiers enhance the
synergistic cytotoxicity of combined nucleoside analog-DNA
alkylating agents in lymphoma cell lines. Exp Hematol. 40:800–810.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nieto Y, Valdez BC, Thall PF, Ahmed S,
Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, et
al: Vorinostat combined with high-dose gemcitabine, busulfan, and
melphalan with autologous stem cell transplantation in patients
with refractory lymphomas. Biol Blood Marrow Transplant.
21:1914–1920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Köck K, Grube M, Jedlitschky G, Oevermann
L, Siegmund W, Ritter CA and Kroemer HK: Expression of adenosine
triphosphate-binding cassette (ABC) drug transporters in peripheral
blood cells: Relevance for physiology and pharmacotherapy. Clin
Pharmacokinet. 46:449–470. 2007. View Article : Google Scholar : PubMed/NCBI
|
